← Back to Analyst Consensus 
OKYO Buy
OKYO Pharma Ltd
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 20, 2026 | Piper Sandler | initiate | — → Overweight | $7 | 54% |
| Dec 8, 2025 | B. Riley Securities | initiate | — → Buy | $5 | 54% |
| Sep 23, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| May 5, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Feb 18, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Feb 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Feb 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Oct 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Oct 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Aug 27, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jul 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jul 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Mar 22, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Jan 8, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Dec 5, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Nov 2, 2023 | HC Wainwright & Co. | initiate | — → Buy | $4 | 44% |
Price Target Trend
Jun 19, 2026 Latest: $8.33 Oct 25, 2026
EPS Estimates
+1q $-0.04
Lo: $-0.04 Hi: $-0.04
1 analysts +1y $-0.66
Lo: $-0.66 Hi: $-0.66
1 analysts 0y $-0.12
Lo: $-0.12 Hi: $-0.12
1 analysts ▲1
0q $-0.03
Lo: $-0.03 Hi: $-0.03
1 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days